This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Volume: 12
Published: Jan 1, 2019
Abstract
Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal leukoencephalopathy. However, NTZ interruption may result in recrudescence of disease activity.The objective of this study was to summarize the available evidence about NTZ discontinuation and to identify which patients will experience post-NTZ disease reactivation through meta-analysis of existing...
Paper Details
Title
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
Published Date
Jan 1, 2019
Volume
12
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.